Methodological requirements for realworld cost-effectiveness assessment

Size: px
Start display at page:

Download "Methodological requirements for realworld cost-effectiveness assessment"

Transcription

1 Methodological requirements for realworld cost-effectiveness assessment Ismo Linnosmaa Department of Health and Social Management, UEF Centre for Health and Social Economics, THL Ismo Linnosmaa

2 Outline 1. Basic concepts in cost-effectiveness research 2. How to assess cost-effectiveness: data and methods Concepts treatment, intervention or service are used interchangeably 29/08/2018

3 Basic concepts

4 Framework to assess costs and effectiveness Inputs - costs Output - services Effectiveness - change in well-being or health Productivity is assessed using information on outputs and inputs Cost-effectiveness is assessed using information on costs and effectiveness

5 Effectiveness Well-being/ health Observed well-being/health with the service E = effectiveness Counterfactual effect: Well-being/health without the service Service use begins time

6 Resource use and costs Steps in measuring costs of interventions or services: Choice of perspective for the evaluation; societal perspective recommended Identification and measurement of resource use Valuing the use of resources: opportunity cost of resource use Role of non-medical and future costs Remark: Costs/Cost reduction can also be outcomes of interest

7 Incremental cost-effectiveness ratio Consider old (0) and new (1) technologies with costs C 0 and C 1 outcomes E 0 and E 1 Economic analysis often interested in incremental cost-effectiveness ratio C1 C0 ICER0,1, E E 1 0 measuring the cost of one unit of outcome (e.g. health, QALY or wellbeing) gained when the decision-maker decides to replace the current technology with new technology

8 How to assess cost-effectiveness: data and methods 29/08/2018

9 Data sources Data from controlled experiments (henceforth experimental data) Data collection or measurements are controlled by experimenters or researchers Sample size often relatively small Focus often on specific populations, like e.g. multimorbid patients older than 75 years waiting for a hip replacement Real-world data Is observational (henceforth observational data): records what goes on in the real world Sample size can be large Examples: data from administrative records, survey data, population surveys

10 Randomized controlled trials (RCTs) RCTs are often considered to be the best research designs when measuring causal effects of treatments on outcomes, ie. treatment effects In RCTs: Assignment of individuals to treatment and control groups is controlled by researchers Randomization ensures unbiased estimation of treatment effects Random assignment of subjects to treatment and control groups ensures that on average study subjects are similar in treatment and control groups in all other respects than the treatment; hence Any potential differences in outcomes are caused by the treatment Examples: clinical trials, RAND health insurance experiment (Manning et al. 1987)

11 Drawbacks of RCTs RCTs may be costly to carry out are sometimes considered unethical because of random allocation of subjects Usual practice in health and social care is that services are allocated on the basis of need may not always work as desired Drop-outs after randomization: e.g. more old people die in the treatment group than in the control group (King et al. 2011) Non-compliance to the experimental protocol

12 Observational data and methods In observational data selection into the treatment may not be purely random but affected by other factors like e.g. need of care Treatment effects may be confounded by factors influencing selection Methodological approaches to control systematic selection (Jones and Rice, 2011) to estimate causal effect I Selection on observables: Regression techniques Matching techniques (e.g. propensity score matching) II Selection on unobservables: Instrumental variables estimation Regression discontinuity Difference-in-differences

13 Methodological requirements All methodological approaches go with modelling assumptions that need to be satisfied in causal estimation I Selection on observables: Regression technique assumes conditional independence (CI): Conditional on observables x in regression, outcome and treatment are independent (ie. selection is controlled by observables x) Matching assumes CI and weak overlap of observables in treatment and control groups: overlap creates a possibility to match

14 Methodological requirements II Selection on unobservables: Instrumental variables method assumes existence of strong and valid instruments Regression discontinuity assumes existence of a forcing variable causing a discontinuous change in the assignment to treatment; e.g. eligibility to a disability benefit ends at a certain age Difference-in-differences assumes longitudinal data and parallel trends: without treatment, trends in the treatment and control groups are same Review by Kreif et al. (2013) shows that in the majority of the published cost-effectiveness studies using observational data (N=81), modelling assumptions needed to estimate causal effects were not properly assessed

15 Conclusions Improved availability of real world data increases possibilities to evaluate treatment effects in cost-effectiveness studies When using real world data, it is important to Evaluate the possibility of selection bias, and Apply proper methods to estimate treatment effects

16 Literature Jones AM, Rice N (2011) Econometric evaluation of health policies in Glied S, Smith PC (eds.) The Oxford handbook of Health Economics, Oxford Handbooks, Oxford University Press Kreif N, Grieve R, Sadique MZ (2013) Statistical methods for cost-effectiveness analysis that use observational data: A critical appraisal tool and review of current practice, Health Econ 22: King G, Nielsen R, Coberley C, Pope JE, Wells A (2011) Avoiding randomization failutre in program emavalution, with application to the Medicare Health Support Program, Population Health Management, 14(1): Manning WG, Newhouse JP, Naihua D, Keeler EB, Leibowitz A, Marquis MS (1987) Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment, The American Economic Review, 77(3): /08/2018

17 More information:

Confounding by indication developments in matching, and instrumental variable methods. Richard Grieve London School of Hygiene and Tropical Medicine

Confounding by indication developments in matching, and instrumental variable methods. Richard Grieve London School of Hygiene and Tropical Medicine Confounding by indication developments in matching, and instrumental variable methods Richard Grieve London School of Hygiene and Tropical Medicine 1 Outline 1. Causal inference and confounding 2. Genetic

More information

Version No. 7 Date: July Please send comments or suggestions on this glossary to

Version No. 7 Date: July Please send comments or suggestions on this glossary to Impact Evaluation Glossary Version No. 7 Date: July 2012 Please send comments or suggestions on this glossary to 3ie@3ieimpact.org. Recommended citation: 3ie (2012) 3ie impact evaluation glossary. International

More information

Lecture II: Difference in Difference. Causality is difficult to Show from cross

Lecture II: Difference in Difference. Causality is difficult to Show from cross Review Lecture II: Regression Discontinuity and Difference in Difference From Lecture I Causality is difficult to Show from cross sectional observational studies What caused what? X caused Y, Y caused

More information

Evaluating Social Programs Course: Evaluation Glossary (Sources: 3ie and The World Bank)

Evaluating Social Programs Course: Evaluation Glossary (Sources: 3ie and The World Bank) Evaluating Social Programs Course: Evaluation Glossary (Sources: 3ie and The World Bank) Attribution The extent to which the observed change in outcome is the result of the intervention, having allowed

More information

Can Quasi Experiments Yield Causal Inferences? Sample. Intervention 2/20/2012. Matthew L. Maciejewski, PhD Durham VA HSR&D and Duke University

Can Quasi Experiments Yield Causal Inferences? Sample. Intervention 2/20/2012. Matthew L. Maciejewski, PhD Durham VA HSR&D and Duke University Can Quasi Experiments Yield Causal Inferences? Matthew L. Maciejewski, PhD Durham VA HSR&D and Duke University Sample Study 1 Study 2 Year Age Race SES Health status Intervention Study 1 Study 2 Intervention

More information

Combination therapy compared to monotherapy for moderate to severe Alzheimer's Disease. Summary

Combination therapy compared to monotherapy for moderate to severe Alzheimer's Disease. Summary Combination therapy compared to monotherapy for moderate to severe Alzheimer's Disease Summary Mai 17 th 2017 Background Alzheimer s disease is a serious neurocognitive disorder which is characterized

More information

Alcohol interventions in secondary and further education

Alcohol interventions in secondary and further education National Institute for Health and Care Excellence Guideline version (Draft for Consultation) Alcohol interventions in secondary and further education NICE guideline: methods NICE guideline Methods

More information

Assessing the impact of unmeasured confounding: confounding functions for causal inference

Assessing the impact of unmeasured confounding: confounding functions for causal inference Assessing the impact of unmeasured confounding: confounding functions for causal inference Jessica Kasza jessica.kasza@monash.edu Department of Epidemiology and Preventive Medicine, Monash University Victorian

More information

Recent advances in non-experimental comparison group designs

Recent advances in non-experimental comparison group designs Recent advances in non-experimental comparison group designs Elizabeth Stuart Johns Hopkins Bloomberg School of Public Health Department of Mental Health Department of Biostatistics Department of Health

More information

Effects of propensity score overlap on the estimates of treatment effects. Yating Zheng & Laura Stapleton

Effects of propensity score overlap on the estimates of treatment effects. Yating Zheng & Laura Stapleton Effects of propensity score overlap on the estimates of treatment effects Yating Zheng & Laura Stapleton Introduction Recent years have seen remarkable development in estimating average treatment effects

More information

WHAT TO DO IN ABSENCE OF HEAD TO HEAD CLINICAL TRIAL DATA. Lead the economic evaluation group at CHERE, University of Technology, Sydney

WHAT TO DO IN ABSENCE OF HEAD TO HEAD CLINICAL TRIAL DATA. Lead the economic evaluation group at CHERE, University of Technology, Sydney WHAT TO DO IN ABSENCE OF HEAD TO HEAD CLINICAL TRIAL DATA MIXED TREATMENT COMPARISON (MTC) Stephen Goodall, Associate Professor of Health Economics Centre for Health Economics Research and Evaluation,

More information

Causal Inference in Observational Settings

Causal Inference in Observational Settings The University of Auckland New Zealand Causal Inference in Observational Settings 7 th Wellington Colloquium Statistics NZ 30 August 2013 Professor Peter Davis University of Auckland, New Zealand and COMPASS

More information

Reducing Tobacco Use and Secondhand Smoke Exposure: Interventions to Increase the Unit Price for Tobacco Products

Reducing Tobacco Use and Secondhand Smoke Exposure: Interventions to Increase the Unit Price for Tobacco Products Reducing Tobacco Use and Secondhand Smoke Exposure: Interventions to Increase the Unit Price for Tobacco Products Task Force Finding and Rationale Statement Table of Contents Intervention Definition...

More information

Introduction to Observational Studies. Jane Pinelis

Introduction to Observational Studies. Jane Pinelis Introduction to Observational Studies Jane Pinelis 22 March 2018 Outline Motivating example Observational studies vs. randomized experiments Observational studies: basics Some adjustment strategies Matching

More information

QUASI-EXPERIMENTAL APPROACHES

QUASI-EXPERIMENTAL APPROACHES QUASI-EXPERIMENTAL APPROACHES Experimental approaches work by comparing changes in a group that receives a development intervention with a group that does not. The difference is then attributed to the

More information

RCTs: what s the problem?

RCTs: what s the problem? An approach for using observational data to enhance the external validity of RCTs Richard Grieve richard.grieve@lshtm.ac.uk RCTs: what s the problem? Heavy investment in RCTs Decision-makers want effectiveness

More information

Getting ready for propensity score methods: Designing non-experimental studies and selecting comparison groups

Getting ready for propensity score methods: Designing non-experimental studies and selecting comparison groups Getting ready for propensity score methods: Designing non-experimental studies and selecting comparison groups Elizabeth A. Stuart Johns Hopkins Bloomberg School of Public Health Departments of Mental

More information

Propensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy Research

Propensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy Research 2012 CCPRC Meeting Methodology Presession Workshop October 23, 2012, 2:00-5:00 p.m. Propensity Score Methods for Estimating Causality in the Absence of Random Assignment: Applications for Child Care Policy

More information

Pharmacoeconomics: from Policy to Science. Olivia Wu, PhD Health Economics and Health Technology Assessment

Pharmacoeconomics: from Policy to Science. Olivia Wu, PhD Health Economics and Health Technology Assessment Pharmacoeconomics: from Policy to Science Olivia Wu, PhD Health Economics and Health Technology Assessment Potential conflicts of interest - none 2 Pharmacoeconomics: from policy to science - Why the need

More information

Introductory: Coding

Introductory: Coding Introductory: Coding Sandra Jo Wilson Editor, Education Coordinating Group Associate Director, Peabody Research Institute Research Assistant Professor, Dept. of Special Education Vanderbilt University,

More information

Lecture II: Difference in Difference and Regression Discontinuity

Lecture II: Difference in Difference and Regression Discontinuity Review Lecture II: Difference in Difference and Regression Discontinuity it From Lecture I Causality is difficult to Show from cross sectional observational studies What caused what? X caused Y, Y caused

More information

Essay 3 Advancing quantitative methods for the evaluation of complex interventions

Essay 3 Advancing quantitative methods for the evaluation of complex interventions DOI: 10.3310/hsdr04160-37 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 16 Essay 3 Advancing quantitative methods for the evaluation of complex interventions Clare Gillies, 1 Nick Freemantle, 2

More information

GLOSSARY OF GENERAL TERMS

GLOSSARY OF GENERAL TERMS GLOSSARY OF GENERAL TERMS Absolute risk reduction Absolute risk reduction (ARR) is the difference between the event rate in the control group (CER) and the event rate in the treated group (EER). ARR =

More information

of stratified medicines

of stratified medicines Modelling the cost-effectiveness efficacy of stratified medicines Katherine Payne Health Economics for Stratified Medicine Academy of Medical Sciences & Pharmacogenetics and Stratified Medicine Network

More information

Introduction to Applied Research in Economics Kamiljon T. Akramov, Ph.D. IFPRI, Washington, DC, USA

Introduction to Applied Research in Economics Kamiljon T. Akramov, Ph.D. IFPRI, Washington, DC, USA Introduction to Applied Research in Economics Kamiljon T. Akramov, Ph.D. IFPRI, Washington, DC, USA Training Course on Applied Econometric Analysis June 1, 2015, WIUT, Tashkent, Uzbekistan Why do we need

More information

NICE DSU TECHNICAL SUPPORT DOCUMENT 16: ADJUSTING SURVIVAL TIME ESTIMATES IN THE PRESENCE OF TREATMENT SWITCHING

NICE DSU TECHNICAL SUPPORT DOCUMENT 16: ADJUSTING SURVIVAL TIME ESTIMATES IN THE PRESENCE OF TREATMENT SWITCHING NICE DSU TECHNICAL SUPPORT DOCUMENT 16: ADJUSTING SURVIVAL TIME ESTIMATES IN THE PRESENCE OF TREATMENT SWITCHING REPORT BY THE DECISION SUPPORT UNIT July 2014 Nicholas R Latimer 1 Keith R Abrams 2 1 School

More information

TREATMENT EFFECTIVENESS IN TECHNOLOGY APPRAISAL: May 2015

TREATMENT EFFECTIVENESS IN TECHNOLOGY APPRAISAL: May 2015 NICE DSU TECHNICAL SUPPORT DOCUMENT 17: THE USE OF OBSERVATIONAL DATA TO INFORM ESTIMATES OF TREATMENT EFFECTIVENESS IN TECHNOLOGY APPRAISAL: METHODS FOR COMPARATIVE INDIVIDUAL PATIENT DATA REPORT BY THE

More information

Measuring Impact. Program and Policy Evaluation with Observational Data. Daniel L. Millimet. Southern Methodist University.

Measuring Impact. Program and Policy Evaluation with Observational Data. Daniel L. Millimet. Southern Methodist University. Measuring mpact Program and Policy Evaluation with Observational Data Daniel L. Millimet Southern Methodist University 23 May 2013 DL Millimet (SMU) Observational Data May 2013 1 / 23 ntroduction Measuring

More information

Ec331: Research in Applied Economics Spring term, Panel Data: brief outlines

Ec331: Research in Applied Economics Spring term, Panel Data: brief outlines Ec331: Research in Applied Economics Spring term, 2014 Panel Data: brief outlines Remaining structure Final Presentations (5%) Fridays, 9-10 in H3.45. 15 mins, 8 slides maximum Wk.6 Labour Supply - Wilfred

More information

Econometric analysis and counterfactual studies in the context of IA practices

Econometric analysis and counterfactual studies in the context of IA practices Econometric analysis and counterfactual studies in the context of IA practices Giulia Santangelo http://crie.jrc.ec.europa.eu Centre for Research on Impact Evaluation DG EMPL - DG JRC CRIE Centre for Research

More information

Introduction to Cost-Effectiveness Analysis

Introduction to Cost-Effectiveness Analysis Introduction to Cost-Effectiveness Analysis Janie M. Lee, MD, MSc RSNA Clinical Trials Methodology Workshop January 13, 2016 Why is Clinical Research Important to Radiology? Radiology currently occupies

More information

Can harnessing causal inference with large-scale data enable the health economist to reach the policy-making summit?

Can harnessing causal inference with large-scale data enable the health economist to reach the policy-making summit? Can harnessing causal inference with large-scale data enable the health economist to reach the policy-making summit? Richard Grieve richard.grieve@lshtm.ac.uk Van-HEM: thanks are due Getting (the right)

More information

CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL?

CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL? CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL? Mette Nørgaard, Professor, MD, PhD Department of Clinical Epidemiology Aarhus Universitety Hospital Aarhus, Denmark Danish Medical Birth Registry

More information

Impact Evaluation Toolbox

Impact Evaluation Toolbox Impact Evaluation Toolbox Gautam Rao University of California, Berkeley * ** Presentation credit: Temina Madon Impact Evaluation 1) The final outcomes we care about - Identify and measure them Measuring

More information

Technology appraisal guidance Published: 22 September 2010 nice.org.uk/guidance/ta200

Technology appraisal guidance Published: 22 September 2010 nice.org.uk/guidance/ta200 Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C Technology appraisal guidance Published: 22 September 2010 nice.org.uk/guidance/ta200 NICE 2018. All rights reserved. Subject to

More information

GATE: Graphic Appraisal Tool for Epidemiology picture, 2 formulas & 3 acronyms

GATE: Graphic Appraisal Tool for Epidemiology picture, 2 formulas & 3 acronyms GATE: Graphic Appraisal Tool for Epidemiology 1991-2015 1 picture, 2 formulas & 3 acronyms 1 GATE: Graphic Appraisal Tool for Epidemiology Graphic Architectural Tool for Epidemiology Graphic Approach To

More information

I. Identifying the question Define Research Hypothesis and Questions

I. Identifying the question Define Research Hypothesis and Questions Term Paper I. Identifying the question What is the question? (What are my hypotheses?) Is it possible to answer the question with statistics? Is the data obtainable? (birth weight, socio economic, drugs,

More information

The Effects of Maternal Alcohol Use and Smoking on Children s Mental Health: Evidence from the National Longitudinal Survey of Children and Youth

The Effects of Maternal Alcohol Use and Smoking on Children s Mental Health: Evidence from the National Longitudinal Survey of Children and Youth 1 The Effects of Maternal Alcohol Use and Smoking on Children s Mental Health: Evidence from the National Longitudinal Survey of Children and Youth Madeleine Benjamin, MA Policy Research, Economics and

More information

Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness

Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness of risedronate and strontium ranelate in those people who would be treated with generic

More information

CAUSAL EFFECT HETEROGENEITY IN OBSERVATIONAL DATA

CAUSAL EFFECT HETEROGENEITY IN OBSERVATIONAL DATA CAUSAL EFFECT HETEROGENEITY IN OBSERVATIONAL DATA ANIRBAN BASU basua@uw.edu @basucally Background > Generating evidence on effect heterogeneity in important to inform efficient decision making. Translate

More information

Dealing with uncertainty in the economic evaluation of health care technologies

Dealing with uncertainty in the economic evaluation of health care technologies Dealing with uncertainty in the economic evaluation of health care technologies Susan Claire Griffin, MSc. This thesis was submitted for the qualification of PhD by publications at the University of York

More information

Exploring uncertainty in cost effectiveness analysis. Francis Ruiz NICE International (acknowledgements to: Benjarin Santatiwongchai of HITAP)

Exploring uncertainty in cost effectiveness analysis. Francis Ruiz NICE International (acknowledgements to: Benjarin Santatiwongchai of HITAP) Exploring uncertainty in cost effectiveness analysis Francis Ruiz NICE International (acknowledgements to: Benjarin Santatiwongchai of HITAP) NICE International and HITAP copyright 2013 Why uncertainty

More information

Causal Validity Considerations for Including High Quality Non-Experimental Evidence in Systematic Reviews

Causal Validity Considerations for Including High Quality Non-Experimental Evidence in Systematic Reviews Non-Experimental Evidence in Systematic Reviews OPRE REPORT #2018-63 DEKE, MATHEMATICA POLICY RESEARCH JUNE 2018 OVERVIEW Federally funded systematic reviews of research evidence play a central role in

More information

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Randomized Controlled Trials http://joannabriggs.org/research/critical-appraisal-tools.html www.joannabriggs.org

More information

Jae Jin An, Ph.D. Michael B. Nichol, Ph.D.

Jae Jin An, Ph.D. Michael B. Nichol, Ph.D. IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIAS Jae Jin An, Ph.D. Michael B. Nichol, Ph.D.

More information

1 Executive summary. Background

1 Executive summary. Background 1 Executive summary Background Rheumatoid Arthritis (RA) is the most common inflammatory polyarthropathy in the UK affecting between.5% and 1% of the population. The mainstay of RA treatment interventions

More information

Adverse Outcomes After Hospitalization and Delirium in Persons With Alzheimer Disease

Adverse Outcomes After Hospitalization and Delirium in Persons With Alzheimer Disease Adverse Outcomes After Hospitalization and Delirium in Persons With Alzheimer Disease J. Sukanya 05.Jul.2012 Outline Background Methods Results Discussion Appraisal Background Common outcomes in hospitalized

More information

The cost-effectiveness of interventions in primary care a health economic perspective for decision-making. Miika Linna, Aalto University/HEMA

The cost-effectiveness of interventions in primary care a health economic perspective for decision-making. Miika Linna, Aalto University/HEMA The cost-effectiveness of interventions in primary care a health economic perspective for decision-making Miika Linna, Aalto University/HEMA Introduction 1) Cost-effectiveness and quality improvement differences

More information

CRITICAL APPRAISAL AP DR JEMAIMA CHE HAMZAH MD (UKM) MS (OFTAL) UKM PHD (UK) DEPARTMENT OF OPHTHALMOLOGY UKM MEDICAL CENTRE

CRITICAL APPRAISAL AP DR JEMAIMA CHE HAMZAH MD (UKM) MS (OFTAL) UKM PHD (UK) DEPARTMENT OF OPHTHALMOLOGY UKM MEDICAL CENTRE CRITICAL APPRAISAL AP DR JEMAIMA CHE HAMZAH MD (UKM) MS (OFTAL) UKM PHD (UK) DEPARTMENT OF OPHTHALMOLOGY UKM MEDICAL CENTRE MINGGU PENYELIDIKAN PERUBATAN & KESIHATAN PPUKM Lecture content Introduction

More information

EC352 Econometric Methods: Week 07

EC352 Econometric Methods: Week 07 EC352 Econometric Methods: Week 07 Gordon Kemp Department of Economics, University of Essex 1 / 25 Outline Panel Data (continued) Random Eects Estimation and Clustering Dynamic Models Validity & Threats

More information

CHALLENGES IN THE USE OF REAL-WORLD EVIDENCE FOR PHARMACOECONOMIC MODELLING

CHALLENGES IN THE USE OF REAL-WORLD EVIDENCE FOR PHARMACOECONOMIC MODELLING CHALLENGES IN THE USE OF REAL-WORLD EVIDENCE FOR PHARMACOECONOMIC MODELLING ISPOR Europe 2018, Barcelona, Spain Monday, November 12 th, 2018 Participants and disclosure Pierre Levy, PhD, Associate Professor,

More information

The (mis)use of treatment switching adjustment methods in health technology assessment busting some myths!

The (mis)use of treatment switching adjustment methods in health technology assessment busting some myths! The (mis)use of treatment switching adjustment methods in health technology assessment busting some myths! ISPOR Barcelona, 2018 Dr Nicholas Latimer (n.latimer@sheffield.ac.uk) Reader in Health Economics,

More information

Statistical considerations in indirect comparisons and network meta-analysis

Statistical considerations in indirect comparisons and network meta-analysis Statistical considerations in indirect comparisons and network meta-analysis Said Business School, Oxford, UK March 18-19, 2013 Cochrane Comparing Multiple Interventions Methods Group Oxford Training event,

More information

Propensity scores and instrumental variables to control for confounding. ISPE mid-year meeting München, 2013 Rolf H.H. Groenwold, MD, PhD

Propensity scores and instrumental variables to control for confounding. ISPE mid-year meeting München, 2013 Rolf H.H. Groenwold, MD, PhD Propensity scores and instrumental variables to control for confounding ISPE mid-year meeting München, 2013 Rolf H.H. Groenwold, MD, PhD WP2 WG2: aims Evaluate methods to control for observed and unobserved

More information

Identification of effectheterogeneity. instrumental variables

Identification of effectheterogeneity. instrumental variables Identification of effectheterogeneity using instrumental variables Anirban Basu University of Washington, Seattle and NBER Symposium on OBSERVATIONAL STUDIES IN A LEARNING HEALTH SYSTEM April 25, 2013

More information

Title: New Perspectives on the Synthetic Control Method. Authors: Eli Ben-Michael, UC Berkeley,

Title: New Perspectives on the Synthetic Control Method. Authors: Eli Ben-Michael, UC Berkeley, Title: New Perspectives on the Synthetic Control Method Authors: Eli Ben-Michael, UC Berkeley, ebenmichael@berkeley.edu Avi Feller, UC Berkeley, afeller@berkeley.edu [presenting author] Jesse Rothstein,

More information

Basic Economic Analysis. David Epstein, Centre for Health Economics, York

Basic Economic Analysis. David Epstein, Centre for Health Economics, York Basic Economic Analysis David Epstein, Centre for Health Economics, York Contents Introduction Resource use and costs Health Benefits Economic analysis Conclusions Introduction What is economics? Choices

More information

Research Design. Beyond Randomized Control Trials. Jody Worley, Ph.D. College of Arts & Sciences Human Relations

Research Design. Beyond Randomized Control Trials. Jody Worley, Ph.D. College of Arts & Sciences Human Relations Research Design Beyond Randomized Control Trials Jody Worley, Ph.D. College of Arts & Sciences Human Relations Introduction to the series Day 1: Nonrandomized Designs Day 2: Sampling Strategies Day 3:

More information

Cost-effectiveness of osimertinib (Tagrisso )

Cost-effectiveness of osimertinib (Tagrisso ) Cost-effectiveness of osimertinib (Tagrisso ) for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small-cell lung

More information

Appendix 18d: Computerised cognitive behavioural therapy for panic disorder GRADE evidence profiles

Appendix 18d: Computerised cognitive behavioural therapy for panic disorder GRADE evidence profiles : Computerised cognitive behavioural therapy for panic disorder GRADE evidence profiles versus waitlist control for panic disorder... 2 versus information control for panic disorder... 3 versus any control

More information

CONCEPTUALIZING A RESEARCH DESIGN

CONCEPTUALIZING A RESEARCH DESIGN CONCEPTUALIZING A RESEARCH DESIGN Detty Nurdiati Dept of Obstetrics & Gynecology Fac of Medicine, Universitas Gadjah Mada Yogyakarta, Indonesia Conceptualizing a Research Design The Research Design The

More information

QUASI-EXPERIMENTAL HEALTH SERVICE EVALUATION COMPASS 1 APRIL 2016

QUASI-EXPERIMENTAL HEALTH SERVICE EVALUATION COMPASS 1 APRIL 2016 QUASI-EXPERIMENTAL HEALTH SERVICE EVALUATION COMPASS 1 APRIL 2016 AIM & CONTENTS Aim to explore what a quasi-experimental study is and some issues around how they are done Context and Framework Review

More information

Making sense of published research Two ways: Format Argument

Making sense of published research Two ways: Format Argument Class 3 Making sense of published research Two ways: Format Argument UNDERSTANDİNG FORMAT Three types of research: 1) Survey of the literature http://www.econ.brown.edu/fac/peter_howitt/publi cation/bewleyrev.pdf

More information

Propensity Score Analysis Shenyang Guo, Ph.D.

Propensity Score Analysis Shenyang Guo, Ph.D. Propensity Score Analysis Shenyang Guo, Ph.D. Upcoming Seminar: April 7-8, 2017, Philadelphia, Pennsylvania Propensity Score Analysis 1. Overview 1.1 Observational studies and challenges 1.2 Why and when

More information

Rapid appraisal of the literature: Identifying study biases

Rapid appraisal of the literature: Identifying study biases Rapid appraisal of the literature: Identifying study biases Rita Popat, PhD Clinical Assistant Professor Division of Epidemiology Stanford University School of Medicine August 7, 2007 What is critical

More information

Economic Evaluation. Introduction to Economic Evaluation

Economic Evaluation. Introduction to Economic Evaluation Economic Evaluation Introduction to Economic Evaluation This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of

More information

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial Cleland J G F, Takala A, Apajasalo M,

More information

title authors policy issue How often should you have dental visits? no: 10 date: 27/06/2013

title authors policy issue How often should you have dental visits? no: 10 date: 27/06/2013 no: 10 date: 27/06/2013 title How often should you have dental visits? authors Associate Professor Mark G Gussy Department of Dentistry and Oral Health, La Trobe Rural Health School, Faculty of Health

More information

Project Funded under FP7 - HEALTH Grant Agreement no Funded under FP7 - HEALTH Grant Agreement no

Project Funded under FP7 - HEALTH Grant Agreement no Funded under FP7 - HEALTH Grant Agreement no Developing methods of HTA for medical devices: WP3 - Methods for comparative effectiveness research of medical devices Final Conference November, 13 th 2015 U. Siebert, P. Schnell-Inderst, C. Iglesias,

More information

A Primer on Health Economics & Integrating Findings from Clinical Trials into Health Technology Assessments and Decision Making

A Primer on Health Economics & Integrating Findings from Clinical Trials into Health Technology Assessments and Decision Making Presenter: Chris Cameron CANNeCTIN November 8, 2013 A Primer on Health Economics & Integrating Findings from Clinical Trials into Health Technology Assessments and Decision Making Acknowledgements Vanier

More information

Overview of Study Designs

Overview of Study Designs Overview of Study Designs Kyoungmi Kim, Ph.D. July 13 & 20, 2016 This seminar is jointly supported by the following NIH-funded centers: We are video recording this seminar so please hold questions until

More information

Anna Spurlock, Peter Cappers, Ling Jin, Annika Todd, LBNL Patrick Baylis, University of California at Berkeley

Anna Spurlock, Peter Cappers, Ling Jin, Annika Todd, LBNL Patrick Baylis, University of California at Berkeley Go for the Silver? Evidence from field studies quantifying the difference in evaluation results between gold standard randomized controlled trial methods versus quasi-experimental methods Anna Spurlock,

More information

Cost-effectiveness Analysis for HHS

Cost-effectiveness Analysis for HHS Cost-effectiveness Analysis for HHS Edward Broughton, PhD., MPH Director of Research and Evaluation, USAID ASSIST Project, University Research Co., LLC Ukraine: 1 Mali: 1 Nigeria: 1 2 Uganda: 6 Burundi:

More information

Overview of Study Designs in Clinical Research

Overview of Study Designs in Clinical Research Overview of Study Designs in Clinical Research Systematic Reviews (SR), Meta-Analysis Best Evidence / Evidence Guidelines + Evidence Summaries Randomized, controlled trials (RCT) Clinical trials, Cohort

More information

Systematic Reviews in Education Research: When Do Effect Studies Provide Evidence?

Systematic Reviews in Education Research: When Do Effect Studies Provide Evidence? Systematic Reviews in Education Research: When Do Effect Studies Provide Evidence? Chris van Klaveren and Inge De Wolf TIER WORKING PAPER SERIES TIER WP 13/02 Systematic Reviews in Education Research:

More information

2/20/2012. New Technology #1. The Horizon of New Health Technologies. Introduction to Economic Evaluation

2/20/2012. New Technology #1. The Horizon of New Health Technologies. Introduction to Economic Evaluation Introduction to Economic Evaluation Sean D. Sullivan, PhD Professor and Director Pharmaceutical Outcomes Research and Policy Program University of Washington The Horizon of New Health Technologies Diagnostics:

More information

The role of self-reporting bias in health, mental health and labor force participation: a descriptive analysis

The role of self-reporting bias in health, mental health and labor force participation: a descriptive analysis Empir Econ DOI 10.1007/s00181-010-0434-z The role of self-reporting bias in health, mental health and labor force participation: a descriptive analysis Justin Leroux John A. Rizzo Robin Sickles Received:

More information

Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. Part review of NICE technology appraisal guidance 75 and 106

Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. Part review of NICE technology appraisal guidance 75 and 106 Issue date: September 2010 Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C Part review of NICE technology appraisal guidance 75 and 106 National Institute for Health and Clinical

More information

Introduction to Program Evaluation

Introduction to Program Evaluation Introduction to Program Evaluation Nirav Mehta Assistant Professor Economics Department University of Western Ontario January 22, 2014 Mehta (UWO) Program Evaluation January 22, 2014 1 / 28 What is Program

More information

Setting The setting was primary care. The economic study was conducted in the USA.

Setting The setting was primary care. The economic study was conducted in the USA. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer Zeliadt S B, Etzioni R D, Penson D F, Thompson I M, Ramsey S D Record Status This is a critical abstract of

More information

The impact of treatment line matching on covariates balance and cost effectiveness results: A case study in oncology

The impact of treatment line matching on covariates balance and cost effectiveness results: A case study in oncology The impact of treatment line matching on covariates balance and cost effectiveness results: A case study in oncology Xavier G.L.V. Pouwels Bram L. T. Ramaekers Manuela A. Joore Department of Clinical Epidemiology

More information

Cost-effectiveness of elosulfase alfa (Vimizim ) for the treatment of Morquio A Syndrome in patients of all ages.

Cost-effectiveness of elosulfase alfa (Vimizim ) for the treatment of Morquio A Syndrome in patients of all ages. Cost-effectiveness of elosulfase alfa (Vimizim ) for the treatment of Morquio A Syndrome in patients of all ages. The NCPE has issued a recommendation regarding the cost-effectiveness of elosulfase alfa

More information

The role of Randomized Controlled Trials

The role of Randomized Controlled Trials The role of Randomized Controlled Trials Dr. Georgia Salanti Lecturer in Epidemiology University of Ioannina School of Medicine Outline Understanding study designs and the role of confounding Observational

More information

Outline. Definitions Background Objectives Methodology Results and Discussion Conclusion and Recommendations

Outline. Definitions Background Objectives Methodology Results and Discussion Conclusion and Recommendations An Economic Evaluation of Salt Reduction as a Population Based Intervention for the Prevention of Coronary Heart Disease in Four Eastern Mediterranean Countries (Palestine, Syria, Tunisia, Turkey) Cost

More information

INTRODUCTION TO HEALTH SERVICES RESEARCH POPULATION HEALTH 796. Spring 2014 WARF Room 758 Monday 9:00 AM- 11:30 AM.

INTRODUCTION TO HEALTH SERVICES RESEARCH POPULATION HEALTH 796. Spring 2014 WARF Room 758 Monday 9:00 AM- 11:30 AM. INTRODUCTION TO HEALTH SERVICES RESEARCH POPULATION HEALTH 796 Spring 2014 WARF Room 758 Monday 9:00 AM- 11:30 AM Health Services Research is a multidisciplinary field, both basic and applied, that examines

More information

Stated Preference Methods Research in Health Care Decision Making A Critical Review of Its Use in the European Regulatory Environment.

Stated Preference Methods Research in Health Care Decision Making A Critical Review of Its Use in the European Regulatory Environment. Stated Preference Methods Research in Health Care Decision Making A Critical Review of Its Use in the European Regulatory Environment. Kevin Marsh, Evidera Axel Mühlbacher, Hochschule Neubrandenburg Janine

More information

Clinical and economic consequences of non-adherence

Clinical and economic consequences of non-adherence Clinical and economic consequences of non-adherence Mickaël Hiligsmann Maastricht University, CAPHRI Research Institute, the Netherlands, Department of Public Health Sciences, Belgium ESPACOMP 15 th Annual

More information

ISPOR Good Research Practices for Retrospective Database Analysis Task Force

ISPOR Good Research Practices for Retrospective Database Analysis Task Force ISPOR Good Research Practices for Retrospective Database Analysis Task Force II. GOOD RESEARCH PRACTICES FOR COMPARATIVE EFFECTIVENESS RESEARCH: APPROACHES TO MITIGATE BIAS AND CONFOUNDING IN THE DESIGN

More information

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis Choi H K, Seeger J D, Kuntz K M

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis Choi H K, Seeger J D, Kuntz K M A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis Choi H K, Seeger J D, Kuntz K M Record Status This is a critical abstract of an economic evaluation that meets

More information

What is Multilevel Modelling Vs Fixed Effects. Will Cook Social Statistics

What is Multilevel Modelling Vs Fixed Effects. Will Cook Social Statistics What is Multilevel Modelling Vs Fixed Effects Will Cook Social Statistics Intro Multilevel models are commonly employed in the social sciences with data that is hierarchically structured Estimated effects

More information

CASE STUDY 2: VOCATIONAL TRAINING FOR DISADVANTAGED YOUTH

CASE STUDY 2: VOCATIONAL TRAINING FOR DISADVANTAGED YOUTH CASE STUDY 2: VOCATIONAL TRAINING FOR DISADVANTAGED YOUTH Why Randomize? This case study is based on Training Disadvantaged Youth in Latin America: Evidence from a Randomized Trial by Orazio Attanasio,

More information

Cost-effectiveness of Influenza Vaccine

Cost-effectiveness of Influenza Vaccine Cost-effectiveness of Influenza Vaccine Lisa A. Prosser, PhD, MS Associate Professor University of Michigan National Influenza Vaccine Summit May 16, 2012 Acknowledgments Funding for this research project

More information

Appendix B Fracture incidence and costs by province

Appendix B Fracture incidence and costs by province 1 Appendix B Fracture incidence and costs by province Comprehensive, accurate fracture numbers and costs are very important data that could help with prioritization and allocation of health care resources.

More information

Introduction to Applied Research in Economics

Introduction to Applied Research in Economics Introduction to Applied Research in Economics Dr. Kamiljon T. Akramov IFPRI, Washington, DC, USA Training Course on Introduction to Applied Econometric Analysis November 14, 2016, National Library, Dushanbe,

More information

Causal Methods for Observational Data Amanda Stevenson, University of Texas at Austin Population Research Center, Austin, TX

Causal Methods for Observational Data Amanda Stevenson, University of Texas at Austin Population Research Center, Austin, TX Causal Methods for Observational Data Amanda Stevenson, University of Texas at Austin Population Research Center, Austin, TX ABSTRACT Comparative effectiveness research often uses non-experimental observational

More information

Demographic Responses to a Political Transformation: Evidence of Women s Empowerment from a Natural Experiment in Nepal

Demographic Responses to a Political Transformation: Evidence of Women s Empowerment from a Natural Experiment in Nepal Demographic Responses to a Political Transformation: Evidence of Women s Empowerment from a Natural Experiment in Nepal Jayash Paudel 1 Pedro de Araujo 2 1 University of Massachusetts Amherst 2 Colorado

More information

State-of-the-art Strategies for Addressing Selection Bias When Comparing Two or More Treatment Groups. Beth Ann Griffin Daniel McCaffrey

State-of-the-art Strategies for Addressing Selection Bias When Comparing Two or More Treatment Groups. Beth Ann Griffin Daniel McCaffrey State-of-the-art Strategies for Addressing Selection Bias When Comparing Two or More Treatment Groups Beth Ann Griffin Daniel McCaffrey 1 Acknowledgements This work has been generously supported by NIDA

More information

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York.

Database of Abstracts of Reviews of Effects (DARE) Produced by the Centre for Reviews and Dissemination Copyright 2017 University of York. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling Brown

More information

Comparing Radiation Treatments for Prostate Cancer: What Does the Evidence Tell Us?

Comparing Radiation Treatments for Prostate Cancer: What Does the Evidence Tell Us? Comparing Radiation Treatments for Prostate Cancer: What Does the Evidence Tell Us? Dan Ollendorf, MPH 2nd Annual W.B. Ingalls Memorial Prostate Seminar March 7, 2009 Institute for Clinical and Economic

More information

Appendix. Lifetime extrapolation of data from the randomised controlled DiGEM trial

Appendix. Lifetime extrapolation of data from the randomised controlled DiGEM trial Appendix Lifetime extrapolation of data from the randomised controlled DiGEM trial Judit Simon, Alastair Gray, Philip Clarke, Alisha Wade, Andrew Neil, Andrew Farmer on behalf of the Diabetes Glycaemic

More information